G · Genpact Ltd - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $5.08B | $4.77B | $4.48B | $4.37B | $4.02B | $3.71B |
| Cost of Revenue | $3.25B | $3.08B | $2.91B | $2.83B | $2.59B | $2.42B |
| Gross Profit | $1.83B | $1.69B | $1.57B | $1.54B | $1.43B | $1.29B |
| R&D | - | - | - | - | - | - |
| SG&A | $1.05B | $967.14M | $913.06M | $938.38M | $865.72M | $789.85M |
| Total Operating Expenses | - | - | - | - | - | - |
| D&A | $70.67M | $69.78M | $72.53M | $86.85M | $109.12M | $116.50M |
| Operating Income | $750.21M | $702.06M | $630.86M | $502.15M | $509.00M | $438.72M |
| Interest Expense | - | $79.51M | - | - | - | - |
| Income Tax | $177.65M | $163.15M | ($29.03M) | $111.83M | $113.68M | $92.20M |
| Net Income | $552.49M | $513.67M | $631.25M | $353.40M | $369.45M | $308.28M |
| EPS - Basic | $3.18 | $2.88 | $3.46 | $1.92 | $1.97 | $1.62 |
| EPS - Diluted | $3.13 | $2.85 | $3.41 | $1.88 | $1.91 | $1.57 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $853.84M | $648.25M | $583.67M | $646.76M | $899.46M | $680.44M |
| Accounts Receivable | $1.24B | $1.20B | $1.12B | $994.75M | $887.74M | $881.02M |
| Inventory | - | - | - | - | - | - |
| Accounts Payable | $27.53M | $36.47M | $27.74M | $35.81M | $24.98M | $13.91M |
| Current Assets | $2.66B | $2.08B | $1.89B | $1.78B | $1.92B | $1.75B |
| Total Assets | $5.84B | $4.99B | $4.81B | $4.59B | $4.98B | $4.87B |
| Current Liabilities | $1.60B | $963.74M | $1.32B | $1.10B | $1.31B | $1.20B |
| Long-term Debt | $1.17B | $1.20B | $824.72M | $1.25B | $1.27B | $1.31B |
| Total Liabilities | $3.29B | $2.60B | $2.56B | $2.76B | $3.08B | $3.04B |
| Stockholders' Equity | $2.55B | $2.39B | $2.25B | $1.83B | $1.90B | $1.83B |
| Retained Earnings | $1.39B | $1.24B | $1.09B | $780.01M | $732.47M | $741.66M |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $812.86M | $615.42M | $490.81M | $443.67M | $694.28M | $584.31M |
| Investing Cash Flow | ($495.50M) | ($105.96M) | ($78.94M) | ($36.59M) | ($122.75M) | ($266.40M) |
| Financing Cash Flow | ($106.81M) | ($424.85M) | ($483.00M) | ($571.40M) | ($332.88M) | ($92.01M) |
| CapEx | $78.20M | $82.77M | $55.42M | $50.61M | $53.34M | $70.17M |
| Free Cash Flow | $734.65M | $532.66M | $435.39M | $393.06M | $640.94M | $514.14M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 36.0% | 35.5% | 35.1% | 35.1% | 35.6% | 34.8% |
| Operating margin | 14.8% | 14.7% | 14.1% | 11.5% | 12.7% | 11.8% |
| EBITDA margin | 16.2% | 16.2% | 15.7% | 13.5% | 15.4% | 15.0% |
| Net margin | 10.9% | 10.8% | 14.1% | 8.1% | 9.2% | 8.3% |
| Free cash flow margin | 14.5% | 11.2% | 9.7% | 9.0% | 15.9% | 13.9% |
| FCF / Net income | 1.33 | 1.04 | 0.69 | 1.11 | 1.73 | 1.67 |
| R&D / Revenue | - | - | - | - | - | - |
| SG&A / Revenue | 20.6% | 20.3% | 20.4% | 21.5% | 21.5% | 21.3% |
| Effective tax rate | 24.3% | 24.1% | -4.8% | 24.0% | 23.5% | 23.0% |
| Return on assets | 9.5% | 10.3% | 13.1% | 7.7% | 7.4% | 6.3% |
| Return on equity | 21.7% | 21.5% | 28.1% | 19.4% | 19.5% | 16.8% |
| Return on invested capital | 15.3% | 14.9% | 20.5% | 12.4% | 12.3% | 10.7% |
| Liquidity | ||||||
| Current ratio | 1.66 | 2.16 | 1.44 | 1.61 | 1.47 | 1.45 |
| Quick ratio | 1.66 | 2.16 | 1.44 | 1.61 | 1.47 | 1.45 |
| Cash ratio | 0.53 | 0.67 | 0.44 | 0.59 | 0.69 | 0.57 |
| Leverage | ||||||
| Debt / Equity | 0.46 | 0.50 | 0.37 | 0.68 | 0.67 | 0.71 |
| Debt / Assets | 0.20 | 0.24 | 0.17 | 0.27 | 0.26 | 0.27 |
| Debt / EBITDA | 1.42 | 1.55 | 1.17 | 2.12 | 2.06 | 2.35 |
| Interest coverage | - | 8.8x | - | - | - | - |
| Equity multiplier | 2.29 | 2.09 | 2.14 | 2.51 | 2.62 | 2.66 |
| Liabilities / Assets | 0.56 | 0.52 | 0.53 | 0.60 | 0.62 | 0.62 |
| Efficiency | ||||||
| Asset turnover | 0.87 | 0.96 | 0.93 | 0.95 | 0.81 | 0.76 |
| Inventory turnover | - | - | - | - | - | - |
| Days sales outstanding | 89d | 92d | 91d | 83d | 81d | 87d |
| Days inventory outstanding | - | - | - | - | - | - |
| Days payable outstanding | 3d | 4d | 3d | 5d | 4d | 2d |
| Cash conversion cycle | - | - | - | - | - | - |
| Valuation | ||||||
| P / E | 14.9x | 15.1x | 10.2x | 24.6x | 27.8x | 26.3x |
| P / B | 3.2x | 3.2x | 2.9x | 4.8x | 5.4x | 4.4x |
| P / S | 1.6x | 1.6x | 1.4x | 2.0x | 2.5x | 2.2x |
| EV / EBITDA | 10.4x | 10.7x | 9.5x | 15.8x | 17.2x | 15.7x |
| Growth | ||||||
| Revenue growth (YoY) | 6.6% | 6.5% | 2.4% | 8.7% | 8.4% | 5.4% |
| Revenue CAGR (3y) | 5.1% | 5.8% | 6.5% | 7.5% | 16.1% | - |
| Revenue CAGR (5y) | 6.5% | 6.3% | 11.7% | - | - | - |
| Gross profit growth (YoY) | 8.3% | 7.6% | 2.2% | 7.3% | 10.9% | 5.3% |
| Operating income growth (YoY) | 6.9% | 11.3% | 25.6% | -1.3% | 16.0% | 2.2% |
| Net income growth (YoY) | 7.6% | -18.6% | 78.6% | -4.3% | 19.8% | 1.1% |
| EPS growth (YoY) | 9.8% | -16.4% | 81.4% | -1.6% | 21.7% | 0.6% |
| EPS CAGR (3y) | 18.5% | 14.3% | 29.5% | 6.4% | 9.6% | 5.4% |
| EPS CAGR (5y) | 14.8% | 12.8% | 18.7% | 7.0% | 8.3% | 7.6% |
| FCF growth (YoY) | 37.9% | 22.3% | 10.8% | -38.7% | 24.7% | 45.7% |
| FCF CAGR (5y) | 7.4% | 8.6% | 10.8% | 5.4% | 20.1% | 15.6% |
| Book value growth (YoY) | 6.7% | 6.3% | 23.1% | -3.7% | 3.4% | 8.6% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$5.08B totalHigh Tech And Manufacturing$2.00B · 39.3%
Consumer And Healthcare$1.72B · 34.0%
Financial Services$1.36B · 26.7%
Product / service
$10.16B totalCore Business Services$3.88B · 38.1%
Digital Operations$2.64B · 26.0%
Data Tech AI$2.44B · 24.0%
Advanced Technology Solutions$1.20B · 11.9%
Geographic
$5.08B totalIN$2.98B · 58.7%
Asia Other Than India$788.06M · 15.5%
Americas$730.43M · 14.4%
Europe$578.39M · 11.4%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.92
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
6/9
Neutral
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- ✓No share dilution
- ✓Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Services-Management Consulting Services
Comparing Genpact LTD against the 5 most active filers in the same SIC group.
Dividends
$0.53/share trailing 12 months · -16.1% YoY
| Ex-date | Per share |
|---|---|
| Mar 16, 2026 | $0.1880 |
| Sep 11, 2025 | $0.1700 |
| Jun 18, 2025 | $0.1700 |
| Mar 11, 2025 | $0.1700 |
| Dec 9, 2024 | $0.1530 |
| Sep 11, 2024 | $0.1530 |
| Jun 10, 2024 | $0.1530 |
| Mar 8, 2024 | $0.1530 |
| Dec 7, 2023 | $0.1380 |
| Sep 7, 2023 | $0.1380 |
| Jun 8, 2023 | $0.1380 |
| Mar 9, 2023 | $0.1380 |
| Dec 8, 2022 | $0.1250 |
| Sep 8, 2022 | $0.1250 |
| Jun 9, 2022 | $0.1250 |
| Mar 9, 2022 | $0.1250 |
| Dec 9, 2021 | $0.1080 |
| Sep 9, 2021 | $0.1080 |
| Jun 10, 2021 | $0.1080 |
| Mar 9, 2021 | $0.1080 |
| Dec 8, 2020 | $0.0980 |
| Sep 10, 2020 | $0.0980 |
| Jun 10, 2020 | $0.0980 |
| Mar 6, 2020 | $0.0980 |